Investigational drug · Phase 2
OG-6219
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Endometriosis.
Phase 2Last checked: Nov 19, 2026Latest source record: May 8, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
1
Any phase or sponsor naming "OG-6219"
First trial start
2022
Oct 25, 2022
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "OG-6219", any sponsor or status.
Conditions studied
As listed on its trial records.
- Endometriosis
Approved drugs for the same conditions: Endometriosis · Endocrinology and women's health
Largest trials
Live from ClinicalTrials.gov: studies naming "OG-6219" as an intervention, largest first.
- A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related PainPivotal-lookingCompleted
Organon and CoIndustry
NCT05560646 · 354 participants · Start Oct 25, 2022 · Primary completion May 28, 2025
Drug: OG-6219; Placebo · For: Endometriosis
Sites: Birmingham, Alabama; Los Angeles, California; Orange, Connecticut · 86 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Study to Evaluate the Efficacy and Safety of Linustedastat (OG-6219) in Women with Moderate to Severe Endometriosis-Related Pain.
Arbelaez F, Yureneva J, Larsson P, et al. · Int J Womens Health 2026
Also in development for Endometriosis
- Leuprorelin acetateLeuprolide Open Label, DKF-MA102Phase 33 trials
Pfizer · Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
- KLH-2109Phase 32 trials
JW Pharmaceutical · Menorrhagia, Uterine Fibroids, Endometriosis
- HMI-115Phase 31 trial
Hope Medicine (Nanjing) Co., Ltd · Endometriosis
- VipoglanstatPhase 21 trial
Gesynta Pharma AB · Endometriosis
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.